Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC).
Publication Title
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Document Type
Article
Publication Date
4-1-2019
Clinical Institute
Cancer
Specialty/Research Institute
Earle A. Chiles Research Institute
Specialty/Research Institute
Oncology
Specialty/Research Institute
Pulmonary Medicine
COinS
